Abstract: Following the FDA's 2022 final over-the-counter (OTC) regulations, numerous new products have entered the market. It’s imperative for the strengths and limitations of OTCs to be well-known to feel confident that these devices are able to appropriately compensate for mild-to-moderate hearing loss. In this session you will learn the clinical evidence base for Eargo self-fitting hearing-aids including: confirmation to ANSI standards, accuracy of in-situ audiometry, accuracy of self-fitting to prescriptive targets, and clinically validated subjective/objective outcome measures to assess user benefits. Allowing the data to elevate your confidence, discover how Eargo devices can become part of your practice.
Learning Objectives:
Describe Eargo devices’ objective and subjective clinical evidence.
Describe how Eargo OTC hearing aids can become part of your clinical practice.
